Fineline Cube

Follow:
14778 Articles
Fosun Pharmaceutical Reports Q3 2024 Revenue Growth and R&D Progress
Company

Fosun Pharmaceutical Reports Q3 2024 Revenue Growth and R&D Progress

Shanghai Pharmaceuticals Reports Q3 2024 Revenue Growth, Strengthens Drug Pipeline
Company

Shanghai Pharmaceuticals Reports Q3 2024 Revenue Growth, Strengthens Drug Pipeline

Innovent Biologics' Picankibart Shows 64.6% Skin Clearance in Phase II Psoriasis Study
CompanyDrug

Innovent Biologics’ Picankibart Shows 64.6% Skin Clearance in Phase II Psoriasis Study

Livzon Pharmaceutical's Leuprorelin Acetate Microspheres Passes China's GQCE
CompanyDrug

Livzon Pharmaceutical’s Leuprorelin Acetate Microspheres Passes China’s GQCE

Xi'an Xintong Pharma's Pradefavir Wins NMPA Nod for Chronic Hepatitis B Treatment
CompanyDrug

Xi’an Xintong Pharma’s Pradefavir Wins NMPA Nod for Chronic Hepatitis B Treatment

Eli Lilly's Mounjaro Approved in Hong Kong for Obesity and Type 2 Diabetes Treatment
CompanyDrug

Eli Lilly’s Mounjaro Approved in Hong Kong for Obesity and Type 2 Diabetes Treatment

Clover Biopharmaceuticals Reports Strong Phase I Results for RSV Vaccine SCB-1019
CompanyDrug

Clover Biopharmaceuticals Reports Strong Phase I Results for RSV Vaccine SCB-1019

Merck and Moderna Launch Phase III Study for Individualized Neoantigen Therapy in Lung Cancer
CompanyDrug

Merck and Moderna Launch Phase III Study for Individualized Neoantigen Therapy in Lung Cancer

Merck's Keytruda Gains Two Additional EU Indications for Gynecologic Cancer Treatment
CompanyDrug

Merck’s Keytruda Gains Two Additional EU Indications for Gynecologic Cancer Treatment

WuXi AppTec Reports Q3 2024 Revenues of RMB 10.46 Billion Amid Biosecure Act Challenges
Company

WuXi AppTec Reports Q3 2024 Revenues of RMB 10.46 Billion Amid Biosecure Act Challenges

Monte Rosa Therapeutics Strikes Licensing Deal with Novartis for VAV1 Degraders
CompanyDeals

Monte Rosa Therapeutics Strikes Licensing Deal with Novartis for VAV1 Degraders

Jiangsu Hengrui Medicine Advances Clinical Trials for Cancer Therapies with NMPA Clearance
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Advances Clinical Trials for Cancer Therapies with NMPA Clearance